Follow POL on Twitter The May 8 Forbes prints my letter critical of their earlier story on Serevent/Advair litigation. Press coverage of the Forbes story is being criticized for causing undue panic. (Liv Osby, "Advair story causes alarm among some asthma sufferers", Greeneville News, Apr. 7).
Asthma lawsuits: Glaxo and Serevent & Advair
 |
| Isaac Gorodetski Project Manager, Center for Legal Policy at the Manhattan Institute igorodetski@manhattan-institute.org |
 |
| Laura Eyi Press Officer, Manhattan Institute leyi@manhattan-institute.org |
